Mija, L. A., & Elkrief, A. (2025). Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?. Canadian Oncology Today, 2(1), 13–17. https://doi.org/10.58931/cot.2025.2131